Skip to main content
Log in

The insulin-like growth factor system as a target in breast cancer

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

Evidence from several experimental systems has shown that the insulin-like growth factors (IGFs) can stimulate breast cancer proliferation. Since IGF action is mediated by interaction with specific cell surface receptors, interruption of these signalling pathways could result in inhibition of cellular growth. In all extracellular fluids, the IGFs are associated with high affinity binding proteins, the IGFBPs. Although the function of each IGFBP is not known, it is clear that under certain circumstances the IGFBPs can bind the IGFs and prevent receptor activation, and thus might have a role in a targeted approach to breast cancer therapy. Here we present our studies using IGFBP-1 to inhibit growth of the breast cancer cell line MCF-7.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Clemmons DR: IGF binding proteins and their functions. Mol Reprod Dev 35:368–375, 1993

    Google Scholar 

  2. Nishimoto I: The IGF-II receptor system — a Gprotein-linked mechanism. Mol Reprod Dev 35: 398–407, 1993

    Google Scholar 

  3. Pessin JE, Frattali AL: Molecular dynamics of insulin/IGF-I receptor transmembrane signaling. Mol Reprod Dev 35:339–345, 1993

    Google Scholar 

  4. LeRoith D, Kavsan VM, Koval AP, Roberts CT: Phylogeny of the insulin-like growth factors (IGFs) and receptors — a molecular approach. Mol Reprod Dev 35:332–338, 1993

    Google Scholar 

  5. Daughaday WH, Rotwein P: Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev 10:68–91, 1989

    Google Scholar 

  6. Amselem S, Duquesnoy P, Attree O: Laron dwarfism and mutations of the growth hormone receptor gene. N Engl J Med 321:989–995, 1989

    Google Scholar 

  7. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A: Mice carrying null mutations of the genes encoding insulin-like growth factor-I (Igf-1) and type-1 IGF receptor (Igflr). Cell 75:59–72, 1993

    Google Scholar 

  8. Baker J, Liu JP, Robertson EJ, Efstratiadis A: Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75:73–82, 1993

    Google Scholar 

  9. Ullrich A, Gray A, Tam AW, Yang Feng T, Tsubokawa M, Collins C, Henzel W, Le Bon T, Kathuria S, Chen E, Jacobs S, Francke U, Ramachandran J, Fujita-Yamaguchi Y: Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define hormonal specificity. EMBO J 5:2503–2512, 1986

    Google Scholar 

  10. Steele-Perkins G, Turner J, Edman JC, Hari J, Pierce SB, Stover C, Rutter WJ, Roth RA: Expression and characterization of a functional human insulin-like growth factor I receptor. J Biol Chem 263:11486–11492, 1988

    Google Scholar 

  11. Russel WE, Van Wyk JJ, Pledger WJ: Inhibition of the mitogenic effects of plasma by a monoclonal antibody to somatomedin C. Proc Natl Acad Sci USA 81:2389–2391, 1984

    Google Scholar 

  12. Stiles CD, Capone GT, Scher CD, Antoniades HN, Van Wyk JJ, Pledger WJ: Dual control of cell growth by somatomedins and platelet-derived growth factor. Proc Natl Acad Sci USA 76:1279–1283, 1979

    Google Scholar 

  13. Pietrzkowski Z, Lammers R, Carpenter G, Soderquist AM, Limardo M, Phillips PD, Ullrich A, Baserga R: Constitutive expression of insulin-like growth factor 1 and insulin-like growth factor 1 receptor abrogates all requirements for exogenous growth factors. Cell Growth Diff 3:195–205, 1992

    Google Scholar 

  14. Morgan DO, Edman JC, Standring DN, Fried VA, Smith MC, Roth RA, Rutter WJ: Insulin-like growth factor II receptor as a multifunctional binding protein. Nature 329:301–307, 1987

    Google Scholar 

  15. Roth RA: Structure of the receptor for insulin-like growth factor II: the puzzle amplified. Science 239:1269–1271, 1988

    Google Scholar 

  16. Nishimoto I, Murayama Y, Katada T, Ui M, Ogata E: Possible direct linkage of insulin-like growth factor II receptor with guanine nucleotide-binding protein. J Biol Chem 264:14029–14038, 1989

    Google Scholar 

  17. Murayama Y, Okamoto T, Ogata E, Asano T, Iiri T, Katada T, Ui M, Grubb JH, Sly WS, Nishimoto I: Distinctive regulation of the functional linkage between the human cation-independent mannose 6-phosphate receptor and GTP-binding proteins by insulin-like growth factor II and mannose 6-phosphate. J Biol Chem 265:17456–17462, 1990

    Google Scholar 

  18. Treadway JL, Frattali AL, Pessin JE: Intramolecular subunit interactions between insulin and insulin-Like growth factor-1 αβ half-receptors induced by ligand and Mn/MgATP binding. Biochem 31:11801–11805, 1992

    Google Scholar 

  19. Soos MA, Field CE, Siddle K: Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity. Biochem J 290:419–426, 1993

    Google Scholar 

  20. Moxham CP, Duronio V, Jacobs S: Insulin-like growth factor I receptor β-subunit heterogeneity, evidence for hybrid tetramers composed of insulin-like growth factor I and insulin receptor heterodimers. J Biol Chem 264:13238–13244, 1989

    Google Scholar 

  21. Shimasaki S, Ling N: Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5, and -6). Progr Growth Factor Res 3:243–266, 1991

    Google Scholar 

  22. Jones JI, D'Ercole AJ, Camacho-Hubner C, Clemmons DR: Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: effects of affinity for IGF-I. Proc Natl Acad Sci USA 88:7481–7485, 1991

    Google Scholar 

  23. Jones JI, Gockerman A, Busby WH Jr, Wright G, Clemmons DR: Insulin-like growth factor binding protein-1 stimulates cell migration and binds α5β1 integrin by means of its arg-gly-asp sequence. Proc Natl Acad Sci USA 90:10553–10557, 1993

    Google Scholar 

  24. Myal Y, Shiu RPC, Bhaumick B, Bala M: Receptor binding and growth-promoting activity of insulin-like growth factors in human breast cancer cells (T-47D) in culture. Cancer Res 44:5486–5490, 1984

    Google Scholar 

  25. Yee D, Cullen KJ, Paik S, Perdue JF, Hampton B, Schwartz A, Lippman ME, Rosen N: Insulin-like growth factor II mRNA expression in human breast cancer. Cancer Res 48:6691–6696, 1988

    Google Scholar 

  26. Cullen KJ, Yee D, Sly WS, Perdue J, Hampton B, Lippman ME, Rosen N: Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res 50:48–53, 1990

    Google Scholar 

  27. Osborne CK, Coronado EB, Kitten LJ, Arteaga CL, Fuqua SAW, Ramasharma K, Marshall M, Li CH: Insulin-like growth factor II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor. Mol Endocrinol 3:1701–1709, 1989

    Google Scholar 

  28. Arteaga CL, Osborne CK: Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor. Cancer Res 49:6237–6241, 1989

    Google Scholar 

  29. Mathieu M, Rochefort H, Barenton B, Prebois C, Vignon F: Interactions of cathepsin-D and insulin-like growth factor II (IGF-II) on the IGF-II/mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II. Mol Endocrinol 4:1327–1335, 1990

    Google Scholar 

  30. Yee D, Paik S, Lebovic GS, Marcus RR, Favoni RE, Cullen KJ, Lippman ME, Rosen N: Analysis of IGF-I gene expression in malignancy, evidence for a paracrine role in human breast cancer. Mol Endocrinol 3:509–517, 1989

    Google Scholar 

  31. Ahmed SR, Manni A, Gray G, Hammond JM: Characterization and hormonal regulation of radioimmunoassayable IGF-I (insulin-like growth factor I) like activity and IGF-binding proteins secreted by human breast cancer cells. Anticancer Res 10:1217–1224, 1990

    Google Scholar 

  32. Daly RJ, Harris WH, Wang DY, Darbre PD: Autocrine production of insulin-like growth factor II using an inducible expression system results in reduced estrogen sensitivity of MCF-7 human breast cancer cells. Cell Growth Diff 2:457–464, 1991

    Google Scholar 

  33. Cullen KJ, Lippman ME, Chow D, Hill S, Rosen N, Zwiebel JA: Insulin-like growth factor-II expression in MCF-7 cells induces phenotypic changes associated with malignant progression. Mol Endocrinol 6:91–100, 1992

    Google Scholar 

  34. Stewart AJ, Johnson MD, May FEB, Westley BR: Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells. J Biol Chem 265:21172–21178, 1990

    Google Scholar 

  35. Arteaga CL, Kitten LJ, Coronado EB, Jacobs S, Kull FC Jr, Allred DC, Osborne CK: Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice. J Clin Invest 84:1418–1423, 1989

    Google Scholar 

  36. Brünner N, Yee D, Kern FG, Spang-Thomsen M, Lippman ME, Cullen KJ: Effect of endocrine therapy on growth of T61 human breast cancer xenografts is directly correlated to a specific down-regulation of insulin-like growth factor-II (IGF-II). Eur J Cancer 29A:562–569, 1993

    Google Scholar 

  37. Paik S: Expression of IGF-I and IGF-II mRNA in breast tissue. Breast Cancer Res Treat 22:31–38, 1992

    Google Scholar 

  38. Jammes H, Peyrat JP, Ban E, Vilain MO, Haour F, Djiane J, Bonneterre J: Insulin-like growth factor-1 receptors in human breast tumours — localisation and quantification by histo-autoradiographic analysis. Br J Cancer 66:248–253, 1992

    Google Scholar 

  39. Bonneterre J, Peyrat JP, Beuscart R, Demaille A: Prognostic significance of insulin-like growth factor I receptors in human breast cancer. Cancer Res 50:6931–6935, 1990

    Google Scholar 

  40. Foekens JA, Portengen H, van Putten WLJ, Trapman AM, Reubi J-C, Alexieva-Figusch J, Klijn JGM: Prognostic value of receptors for insulin-like growth factor I, somatostatin, and epidermal growth factor in human breast cancer. Cancer Res 49:7002–7009, 1989

    Google Scholar 

  41. Papa V, Gliozzo B, Clark GM, McGuire WL, Moore D, Fujita-Yamaguchi Y, Vigneri R, Goldfine ID, Pezzino V: Insulin-like growth factor-I receptors are overexpressed and predict a low risk in human breast cancer. Cancer Res 53:3736–3740, 1993

    Google Scholar 

  42. Papa V, Hartmann KKP, Rosenthal SM, Maddux BA, Siiteri PK, Goldfine ID: Progestins induce down-regulation of insulin-like growth factor-I receptors in human breast cancer cells: potential autocrine role for IGF-II. Mol Endocrinol 5:709–717, 1991

    Google Scholar 

  43. Peyrat JP, Bonneterre J, Hecquet B, Vennin P, Louchez MM, Fournier C, Lefebvre J, Demaille A: Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer. Eur J Cancer 29A:492–497, 1993

    Google Scholar 

  44. Pollak M, Costantino J, Polychronakos C, Blauer S-A, Guyda H, Redmond C, Fisher B, Margolese R: Effect of tamoxifen on serum insulin-like growth factor I levels in stage I breast cancer patients. J Natl Cancer Inst 82:1693–1697, 1990

    Google Scholar 

  45. Friedl A, Jordan VC, Pollak M: Suppression of serum insulin-like growth factor-1 levels in breast cancer patients during adjuvant tamoxifen therapy. Eur J Cancer 29A:1368–1372, 1993

    Google Scholar 

  46. Torrisi R, Pensa F, Orengo MA, Catsafados E, Ponzani P, Boccardo F, Costa A, Decensi A: The synthetic retinoid fenretinide lowers plasma insulin-like growth factor-I levels in breast cancer patients. Cancer Res 53:4769–4771, 1993

    Google Scholar 

  47. Reed MJ, Christodoulides A, Koistinen R, Seppala M, Teale JD, Ghilchik MW: The effect of endocrine therapy with medroxyprogesterone acetate, 4-hydroxy-androstenedione or tamoxifen on plasma concentrations of insulin-like growth factor (IGF)-I, IGF-II and IGFBP-1 in women with advanced breast cancer. Int J Cancer 52:208–212, 1992

    Google Scholar 

  48. Clemmons DR, Camacho-Hubner C, Coronado E, Osborne CK: Insulin-like growth factor binding protein secretion by breast carcinoma cell lines: correlation with estrogen receptor status. Endocrinol 127:2679–2686, 1990

    Google Scholar 

  49. Yee D, Favoni RE, Lippman ME, Powell DR: Identification of insulin-like growth factor binding proteins in breast cancer cells. Breast Cancer Res Treat 18:3–10, 1991

    Google Scholar 

  50. McGuire WL Jr, Jackson JG, Figueroa JA, Shimasaki S, Powell DR, Yee D: Regulation of insulin-like growth factor-binding protein (IGFBP) expression by breast cancer cells: use of IGFBP-1 as an inhibitor of insulin-like growth factor action. J Natl Cancer Inst 84:1336–1341, 1992

    Google Scholar 

  51. Fontana JA, Burrows-Mezu A, Clemmons DR, LeRoith D: Retinoid modulation of insulin-like growth factor-binding proteins and inhibition of breast carcinoma proliferation. Endocrinol 128:1115–1122, 1991

    Google Scholar 

  52. Oh YM, Muller HL, Lamson G, Rosenfeld RG: Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells — cell surface binding and growth inhibition. J Biol Chem 268:14964–14971, 1993

    Google Scholar 

  53. Oh Y, Mueller HL, Pham Y, Rosenfeld RG: Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells. J Biol Chem 268:26045–26048, 1993

    Google Scholar 

  54. Figueroa JA, Jackson JG, McGuire WL, Krywicki RF, Yee D: Expression of insulin-like growth factor binding proteins in human breast cancer correlates with estrogen receptor status. J Cell Biochem 52:196–205, 1993

    Google Scholar 

  55. Shao ZM, Sheikh MS, Ordonez JV, Feng P, Kute T, Chen JC, Aisner S, Schnaper L, LeRoith D, Roberts CT, Fontana J: IGFBP-3 gene expression and estrogen receptor status in human breast carcinoma. Cancer Res 52:5100–5103, 1992

    Google Scholar 

  56. Arteaga CL, Coronado E, Osborne CK: Blockade of the epidermal growth factor receptor inhibits transforming growth factor-α induced but not estrogen induced growth of hormone dependent human breast cancer. Mol Endocrinol 2:1064–1069, 1988

    Google Scholar 

  57. Luetteke NC, Qiu TH, Pieffer RL, Oliver P, Smithies O, Lee DC: TGF-alpha deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice. Cell 73:263–278, 1993

    Google Scholar 

  58. Busby WH Jr, Klapper DG, Clemmons DR: Purification of a 31,000-dalton insulin-like growth factor binding protein from human amniotic fluid, isolation of two forms with different biological actions. J Biol Chem 263:14203–14210, 1988

    Google Scholar 

  59. Elgin RG, Busby WH Jr, Clemmons DR: An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. Proc Natl Acad Sci USA 84:3254–3258, 1987

    Google Scholar 

  60. Figueroa JA, Sharma J, Jackson JG, McDermott MJ, Hilsenbeck SG, Yee D: Recombinant insulin-like growth factor binding protein-1 inhibits IGF-I, serum, and estrogen-dependent growth of MCF-7 human breast cancer cells. J Cell Physiol 157:229–236, 1993

    Google Scholar 

  61. Yee D, Jackson JG, Kozelsky TW, Figueroa JA: Expression of insulin-like growth factor-I inhibits IGF-I mediated growth in MCF-7. Cell Growth Diff 5:73–77, 1994

    Google Scholar 

  62. Camacho-Hubner C, McCusker RH, Clemmons DR: Secretion and biological actions of insulin-like growth factor binding proteins in two human tumor-derived cell lines in vitro. J Cell Physiol 148:281–289, 1991

    Google Scholar 

  63. Yee D, Favoni RE, Lupu R, Cullen KJ, Lebovic GS, Huff KK, Lee PDK, Lee YL, Powell DR, Dickson RB, Rosen N, Lippman ME: The insulin-like growth factor binding protein BP-25 is expressed by human breast cancer cells. Biochem Biophys Res Commun 158:38–44, 1989

    Google Scholar 

  64. Young SCJ, Miles MV, Clemmons DR: Determination of the pharmacokinetic profiles of insulin-like growth factor binding protein-1 and protein-2 in rats. Endocrinol 131:1867–1873, 1992

    Google Scholar 

  65. Trojan J, Blossey BK, Johnson TR, Rudin SD, Tykocinski M, Ilan J, Ilan J: Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor-I. Proc Natl Acad Sci USA 89:4874–4878, 1992

    Google Scholar 

  66. Trojan J, Johnson TR, Rudin SD, Ilan J, Tykocinski ML, Ilan J: Treatment and prevention of rat glioblastoma by immunogenic c6 cells expressing antisense insulin-like growth factor-I RNA. Science 259:94–97, 1993

    Google Scholar 

  67. Culver KW, Ram Z, Wallbridge S, Ishii H, Oldfield EH, Blaese RM: In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256:1550–1552, 1992

    Google Scholar 

  68. Berns EMJJ, Klijn JGM, van Staveren IL, Portengen H, Foekens JA: Sporadic amplification of the insulin-like growth factor I receptor gene in human breast tumors. Cancer Res 52:1036–1039, 1992

    Google Scholar 

  69. Porcu P, Ferber A, Pietrzkowski Z, Roberts CT, Adamo M, LeRoith D, Baserga R: The growth-stimulatory effect of simian virus-40 T-antigen requires the interaction of insulin-like growth factor-1 with its receptor. Mol Cell Biology 12:5069–5077, 1992

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yee, D. The insulin-like growth factor system as a target in breast cancer. Breast Cancer Res Tr 32, 85–95 (1994). https://doi.org/10.1007/BF00666209

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00666209

Key words

Navigation